Clinical Trial Update: A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly [Phase 2]

View source ↗

Summary

Phase 2 study evaluating an adherence plan to help HIV-positive patients take their first antiretroviral medications correctly. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED